Task Practice and Spinal Cord Stimulation

Inclusion Criteria:

• 22-70 years of age

• Non-progressive cervical spinal cord injury

• Minimum 12 months year post-injury.

• American Spinal Injury Association (ASIA) Impairment Scale (AIS) classification B,C, or D.

• Able to take part in upper extremity therapy procedures.

• GRASSP-Prehension score ≥10.

• MAS Score ≥3 but <6 in at least one arm.

• Can commit to the time required for the study.

• Stable medication profile for at least 4 weeks prior to enrollment.

• Able to reduce Baclofen dose to 30 mg or less daily.

• Capable of providing informed consent.

Exclusion Criteria:

• Has any unstable or significant medical condition that is likely to interfere withstudy procedures like severe neuropathic pain, depression, mood disorders, or othercognitive disorders.

• Has uncontrolled cardiopulmonary disease or cardiac symptoms.

• Requires ventilator support.

• Has been diagnosed with autonomic dysreflexia that is severe, unstable, anduncontrolled.

• Has an autoimmune etiology of spinal cord dysfunction/injury

• Previously diagnosed as having transverse myelitis

• History of additional neurologic diseases such as stroke, multiple sclerosis,traumatic brain injury, epilepsy or history of seizures.

• Peripheral neuropathy (diabetic polyneuropathy, entrapment neuropathy, etc.)

• Uncontrolled spasms, which have been unstable over the past three months prior toenrollment and are not expected to change.

• Received Botulinum toxin injections in their upper extremity, neck, or hand withinsix months prior to enrollment.

• Has painful musculoskeletal dysfunction, unhealed fracture, contracture, pressuresore, or urinary tract infection at the time of enrollment.

• Breakdown in skin area that will come into contact with electrodes.

• Presence of syringomyelia as determined by an MRI.

• Currently undergoing treatment for cancer or has been in remission for less than 2years.

• Received stem cell treatment within the past two years prior to enrollment.

• Has any active implanted medical device.

• Concurrent participation in another drug or device trial that may interfere withthis study.

• In the opinion of the investigators, the study is not safe or appropriate for theparticipant.

• Persons who are unable to consent, pregnant women, and prisoners.